Inhibition of tyrosine kinase receptors by SU6668 promotes abnormal stromal development at the periphery of carcinomas.

Source:http://linkedlifedata.com/resource/pubmed/id/19384298

Br. J. Cancer 2009 May 19 100 10 1575-80

Download in:

View as

General Info

PMID
19384298